Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,106 | 218,044 | 293,477 | 507,144 | 79,449 |
| Marketable Securities | 907,405 | 1,118,171 | 571,930 | 962,553 | 335,907 |
| Other current assets | 0 | 0 | 1,226 | 5,674 | 0 |
| TOTAL | $1,064,137 | $1,372,319 | $897,234 | $1,495,655 | $430,031 |
| Non-Current Assets | |||||
| PPE Net | 45,589 | 44,087 | 38,865 | 40,846 | 46,732 |
| Investments And Advances | 0 | 0 | 425,449 | 32,699 | 39,886 |
| Other Non-Current Assets | 44,191 | 43,836 | 42,614 | 35,080 | 36,582 |
| TOTAL | $89,780 | $87,923 | $506,928 | $108,625 | $123,200 |
| Total Assets | $1,153,917 | $1,460,242 | $1,404,162 | $1,604,280 | $553,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,483 | 2,790 | 4,779 | 1,071 | 2,590 |
| Accrued Expenses | 68,499 | 66,691 | 53,165 | 47,145 | N/A |
| Other current liabilities | N/A | 294,441 | 320,301 | 23,483 | 42,754 |
| TOTAL | $77,982 | $363,922 | $378,245 | $71,699 | $45,344 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44,981 | 53,890 | 63,626 | 382,050 | 112,997 |
| TOTAL | $44,981 | $53,890 | $63,626 | $382,050 | $112,997 |
| Total Liabilities | $122,963 | $417,812 | $441,871 | $453,749 | $158,341 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,160 | 136,678 | 122,833 | 120,984 | 105,423 |
| Common Shares | 1,711 | 1,686 | 1,548 | 1,531 | 1,288 |
| Retained earnings | -1,116,211 | -970,987 | -644,996 | -354,415 | -425,551 |
| Other shareholders' equity | 643 | -6,886 | -2,499 | -245 | 350 |
| TOTAL | $1,030,954 | $1,042,430 | $962,291 | $1,150,531 | $394,890 |
| Total Liabilities And Equity | $1,153,917 | $1,460,242 | $1,404,162 | $1,604,280 | $553,231 |